Although blood eosinophils are currently recognized as the main clinical marker of Th2 inflammation, their relevance in identifying asthma severity is still matter of debate.

Relevance of TH2 markers in the assessment and therapeutic management of severe allergic asthma: A real-life perspective

Caminati, M;Festi, G;Olivieri, M;Guerriero, M;Senna, G;
2020-01-01

Abstract

Although blood eosinophils are currently recognized as the main clinical marker of Th2 inflammation, their relevance in identifying asthma severity is still matter of debate.
2020
Asthma Network; Biomarker; Eosinophils; Omalizumab; Severe Asthma; Th2 Inflammation
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/992697
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 13
social impact